Emerging drug discovery strategies for alleviating neuropathic pain

Drug Development Research

Volumn 67, Issue 4, 2006, Pages 287-288

  Jarvis, Michael F ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL; CARBAMAZEPINE; DULOXETINE; ENDOCANNABINOID; ENDOVANILLOID; GABAPENTIN; NICOTINIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; SODIUM CHANNEL; UNCLASSIFIED DRUG;

DRUG RESEARCH; EDITORIAL; HUMAN; MEDICAL LITERATURE; MEDICAL SOCIETY; NEUROPATHIC PAIN; NEUROPHYSIOLOGY;

EID: 33747761303     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20093     Document Type: Editorial

References (5)

1. Hall GC, Carroll D, Parry D, McQuay HJ. 2006. Epidemiology and treatment of neuropathic pain: The UK primary care perspective. Pain 122:156-162.
2. Honore P, Jarvis MF. 2006. Acute and chronic pain. Comp Med Chem 6:(in press).
3. Merskey H, Bugduk N. 1994. Classification of chronic pain, 2nd ed. Seattle: IASP Press.
4. Smith PA. 2004. Neuropathic pain: drug targets for current and future interventions. Drug News Perspect 17:5-17.
5. Woolf CJ, Mannion RJ. 1999. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353:1959-1964.